Terminology Service for NFDI4Health
All terms in LOINC
| Label | Id | Description |
|---|---|---|
| Carbapenem resistance | LP249322-1 | |
| Rg | LP135640-3 | |
| Chido/Rodgers group | LP98133-9 | |
| SARS-CoV-2 (COVID-19) Ag | LP418019-8 | |
| SARS-CoV-2 (COVID-19) | LP417540-4 | |
| Neutrophil.fMLP and PMA stimulated DHR panel | Patient | Hematology and Cell Count Panels | LP428841-3 | |
| Neutrophil.fMLP and PMA stimulated DHR panel | LP428046-9 | |
| T' wave amplitude.lead AVR:Elpot:Pt:Heart:Qn:EKG | 10132-9 | |
| Electrocardiogram measures | MTHU000062 | |
| T' wave amplitude.lead AVR | Heart | EKG measurements | LP407276-7 | |
| SEER site-specific fact 2 | LP100966-3 | |
| GALT gene allele 1 | LP36344-7 | |
| GALT gene | LP36032-8 | |
| Pentazocine:MCnc:Pt:Body fld:Qn | 60150-0 | |
| Pentazocine | Body fluid | Drug toxicology | LP388610-0 | |
| Seizure disorder in last 7D | MTHU034196 | |
| Traumatic brain injury in last 7D | MTHU034197 | |
| Protein or calorie malnutrition or at risk for malnutrition in last 7D | MTHU034198 | |
| Miocamycin:Susc:Pt:Isolate:OrdQn | 18949-8 | |
| Miocamycin | Isolate | Antibiotic susceptibilities | LP380775-9 |